SEROLOGICALS IMPLEMENTS ACCELERATED INTEGRATION PROGRAM

Serologicals has begun the implementation of an accelerated integration program for its research segment. This program includes the integration of several core functions, including business segment management, R&D/business development, marketing, technical support, scientific sourcing, intellectual property/licensing and finance and accounting.

The company expects to achieve operating efficiencies that should result in annual savings of $3.0 million to $3.5 million. The savings will be phased in over the balance of 2005. The company expects to incur one time costs of approximately $2.0 million to $3.0 million in connection with this program as the result of severance costs, retention payments and relocation costs that will be recorded in the quarter ended Oct. 2.

Based in Atlanta, Ga., Serologicals develops consumable biological products, enabling technologies and services in support of biological research, drug discovery, and the bioprocessing of life-enhancing products.